Vale SA
VALE
D.R. Horton
DHI
Taylor Morrison Home
TMHC
Petroleo Brasileiro SA Petrobras
PBR
Ecopetrol
EC
US Stock MarketDetailed Quotes
STOK Stoke Therapeutics
- 8.870
- -0.130-1.44%
Close Mar 18 16:00 ET
- 8.310
- -0.560-6.31%
Pre 08:00 ET
479.67MMarket Cap-5.38P/E (TTM)
8.930High7.705Low1.63MVolume8.630Open9.000Pre Close14.01MTurnover4.38%Turnover RatioLossP/E (Static)54.08MShares17.58052wk High2.09P/B330.08MFloat Cap6.29052wk Low--Dividend TTM37.21MShs Float71.580Historical High--Div YieldTTM13.61%Amplitude3.350Historical Low8.602Avg Price1Lot Size
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Stoke Therapeutics Stock Forum
Stoke Therapeutics Taps Former Vertex COO as Interim CEO Amid Breakthrough Drug Progress
Stoke Therapeutics Receives FDA Breakthrough Therapy Designation for Zorevunersen for the Treatment of Dravet Syndrome
No comment yet